Iovance Biotherapeutics Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock Pharmaceutical Investing
Life Science Big News Roundup: Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement; Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology; BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY® Life Science Investing
K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA Platform Medical Device Investing
Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 Life Science Investing
Q BioMed is Moving Towards Clinical Trials for Autistic Spectrum Disorder Drug Program Biotech Investing
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus Biotech Investing
Naturally Splendid USA and NeutriSci Announce Expanded Binding Terms of Partnership and Added Distribution of HempOmega™ and Cannabidiol (CBD) Sublingual Tablets Cannabis Investing News
Hemispherx Biopharma Signs Clinical Trial Agreement with Roswell Park Comprehensive Cancer Center Pharmaceutical Investing
